Kind Consumer is a healthcare research and development company specialising in respiratory drug delivery and tobacco harm reduction. An example of our innovative work is Voke*, a next generation nicotine inhaler launching later this year and licensed by the Department of Health. With revolutionary valve technology it provides rapid nicotine absorption and craving relief. Headquartered in London, we at Kind Consumer believe that significant progress can be made through new technologies and scientific breakthroughs to improve public health. In order to achieve this, Kind works with a range of stakeholders, organisations and regulators to make sure our products are thoroughly assessed for quality, safety and efficacy. *Voke 0.45mg Inhaler contains nicotine and can be used to reduce, replace or stop smoking. Requires willpower. Always read the leaflet.